Source: BrainStorm Cell Therapeutics, Inc
Postd: May 31, 2006 8:30 am ET
Summary:
BrainStorm Cell Therapeutics, Inc. announced that a new study has demonstrated the ability of human bone marrow-derived stem cells to differentiate into a variety of nerve cell types. These findings support the prospect of using cell therapies derived from adult bone marrow-derived stem cells and demonstrate the potential of developing dopaminergic cells to treat devastating neurological diseases such as Parkinson's disease.
Commentary: Hopefully this development will enable scientists to transform bone marrow-derived stem cells into effective treatments for neurological diseases and conditions.
No comments:
Post a Comment